NATCO Pharma Ltd (NATCOPHARM)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 841.80
% Change: -0.61% (Prev Close: 847.00)

Volume: 2,00,780
% Change: -42.48% (Prev Volume: 3,49,057)

Delivery: 1,28,626
Delivery % : 64.06
% Change: -25.54% (Prev Delivery: 1,72,738)

Turnover: 1,693 Lacs
% Change: -42.98% (Prev Turnover: 2,968)

πŸ’Ή EOD Valuation

P/E Ratio: 8.88
P/B Ratio: 1.98
Market Cap: 15077 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: NATCOPHARM
Market Cap: 15439 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1639.00
52 Week Low: 660.05

All-Time High: 1639.00 Rs.
All-Time Low: 7.60 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-6.41% | 1.60% | 5.70% | -43.98% | 12.25%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 49.56%

Change (3Y | 1Y): 0.76% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 15.52%

Change (3Y | 1Y): 3.87% | -1.97%

DII Holding

DII Holding: 5.81%

Change (3Y | 1Y): -9.49% | 0.17%

Public Holding: 29.12%

🏦 Financial Strength

Debt to Equity: 0.04
Debt: 279.40 Rs. Cr.

Book Value: 424.71 Rs.
Current Ratio: 5.59
Interest Coverage: 95.05
Free Cash Flow: 1300.30 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 4.14%

Sales Growth Qtr (YOY | QoQ):
-2.47% | 8.84%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
18.26% | 31.57% | 4.14%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 3.73%

Profit Growth Qtr (YOY | QoQ):
-28.09% | 18.30%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
33.28% | 139.41% | 3.73%

EPS Rs.

EPS (TTM): 94.78 Rs.

EPS Qtr (Last Year | Latest):
37.32 Rs. | 26.84 Rs.

EPS Annual (Last Annual | Annual March):
77.51 Rs. | 105.26 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
33.72% | 140.92%

Net Profit Rs. Cr.

Net Profit (TTM): 1695.20 Rs. Cr.

Net Profit (Annual - March): 1883.40 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
668.50| 406.00 | 480.30

EBITDA Rs. Cr.

EBITDA (Quarter): 632.70 Rs. Cr.
EBITDA (Previous Yr Ql): 852.90 Rs. Cr.

EBITDA (Annual - March): 2550.50 Rs. Cr.
EBITDA (Previous Annual): 1882.10 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
30.51% | 99.79%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 44.64%

OPM Qtr (Previous | Current):
44.89% | 42.97%

OPM Annual (5 Yrs | Last Yr | March):
38.03% | 43.86% | 49.58%

Return on Equity %

ROE: 28.01%

ROE (5 Yrs | 3 Yrs | Last Yr):
18.27% | 23.87% | 25.92%

Return on Capital Employed %

ROCE: 32.80%

ROCE (5 Yrs | 3 Yrs | Last Yr):
19.54% | 26.86% | 30.10%

Return on Assets %

ROA (TTM): 24.24%

ROA (5 Yrs | 3 Yrs | Last Yr):
14.22% | 19.80% | 22.13%

PEG Ratio: 0.07
Dividend Yield: 0.70%

PE 3 Yrs: 15.40
PE 5 Yrs: 25.41

Dividend Yield: 0.70%

πŸ‘₯ Company

NATCO Pharma Ltd

NATCOPHARM

Promoter Holding: %